Pazopanib (Votrient)
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Pazopanib (Votrient), covering 2010-01-27 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) [Phase 1, Phase 2]